These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

968 related articles for article (PubMed ID: 30101713)

  • 21. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
    Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
    Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
    Pittenger C
    Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
    Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
    Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
    Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J
    BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
    Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
    J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
    [No Abstract]   [Full Text] [Related]  

  • 27. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How frequently are atypical antipsychotics used to treat OCD in a British community mental health team?
    Agius M; Birtwhistle M; Servant D; Zaman R
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S187-93. PubMed ID: 21894133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of obsessive-compulsive disorder.
    Simpson HB
    Curr Top Behav Neurosci; 2010; 2():527-43. PubMed ID: 21309125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological treatment of obsessive compulsive disorder in children/adolescents].
    Nissen JB; Thomsen PH
    Ugeskr Laeger; 2011 Mar; 173(11):801-6. PubMed ID: 21402013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obsessive-Compulsive Disorder: Diagnosis and Management.
    Fenske JN; Petersen K
    Am Fam Physician; 2015 Nov; 92(10):896-903. PubMed ID: 26554283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in the treatment of obsessive-compulsive disorder.
    Leonard HL
    J Clin Psychiatry; 1997; 58 Suppl 14():39-45; discussion 46-7. PubMed ID: 9418745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.
    Sun TF; Lin PY; Wu CK
    Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
    Talaei A; Hosseini FF; Aghili Z; Akhondzadeh S; Asadpour E; Mehramiz NJ; Forouzanfar F
    Can J Physiol Pharmacol; 2020 Apr; 98(4):236-242. PubMed ID: 32228235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of antipsychotics in obsessive compulsive disorder.
    Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM
    Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
    Metin O; Yazici K; Tot S; Yazici AE
    Hum Psychopharmacol; 2003 Aug; 18(6):463-7. PubMed ID: 12923825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive disorder: a critical review of therapeutic perspectives.
    Schruers K; Koning K; Luermans J; Haack MJ; Griez E
    Acta Psychiatr Scand; 2005 Apr; 111(4):261-71. PubMed ID: 15740462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.